Article Information
- Received August 14, 2011
- Revision received October 11, 2011
- Accepted October 31, 2011
- First published December 14, 2011.
- Version of record published December 14, 2011.
Author Information
Author contributions
Author contributions: C.-K.P., Z.-Z.X., T.L., N.L., and R.-R.J. designed research; C.-K.P., Z.-Z.X., T.L., and N.L. performed research; C.-K.P., Z.-Z.X., T.L., and N.L. analyzed data; R.-R.J. and C.N.S. wrote the paper.
Disclosures
- Received August 14, 2011.
- Revision received October 11, 2011.
- Accepted October 31, 2011.
The work was supported in part by National Institutes of Health Grants R01-DE17794 and NS54932 to R.R.J., R01-GM38765 and P01-GM095467 to C.N.S., and R01-NS67686 to both R.R.J. and C.N.S. We thank the Resolvyx Pharmaceuticals Inc. for providing resolvins and Dr. Philip J. Vickers for helpful discussion.
C.N.S. is an inventor on patents (resolvins) assigned to B.W.H. and licensed to Resolvyx Pharmaceuticals. C.N.S. is a scientific founder of Resolvyx Pharmaceuticals and owns equity in the company. C.N.S.' interests were reviewed and are managed by the Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict of interest policies.
- Correspondence should be addressed to Ru-Rong Ji, Department of Anesthesiology, Brigham and Women's Hospital, 75 Francis Street, Medical Research Building, Room 502, Boston, MA 02115. rrji{at}zeus.bwh.harvard.edu
